PL-16 accounting for death as a competing risk in cancer-associated thrombosis studies

Thrombosis Research

Volumn 129, Issue SUPPL. 1, 2012, Pages

  Campigotto, Federico ^a   Neuberg, Donna ^a   Zwicker, Jeffrey I ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer associated thrombosis; Competing risk model; Cumulative incidence function

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

CANCER ASSOCIATED THROMBOSIS; CANCER PATIENT; CONFERENCE PAPER; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; VENOUS THROMBOEMBOLISM; ARTICLE; COMORBIDITY; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; NEOPLASM; PREVALENCE; PROPORTIONAL HAZARDS MODEL; SURVIVAL; SURVIVAL RATE;

CAUSALITY; COMORBIDITY; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; THROMBOSIS;

EID: 84862125039     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(12)70023-3     Document Type: Conference Paper

References (3)

1. EL Kaplan, P Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
2. HT Kim Cumulative incidence in competing risks data and competing risks regression analysis Clin Cancer Res 13 2007 559 565 (Pubitemid 46225362)
3. RJ Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 11141 11154